Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials
@article{Rothwell2011EffectOD, title={Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials}, author={P. Rothwell and F. G. Fowkes and J. F. Belch and H. Ogawa and T. Meade}, journal={The Lancet}, year={2011}, volume={377}, pages={31-41} }
BACKGROUND
Treatment with daily aspirin for 5 years or longer reduces subsequent risk of colorectal cancer. Several lines of evidence suggest that aspirin might also reduce risk of other cancers, particularly of the gastrointestinal tract, but proof in man is lacking. We studied deaths due to cancer during and after randomised trials of daily aspirin versus control done originally for prevention of vascular events.
METHODS
We used individual patient data from all randomised trials of daily… CONTINUE READING
Figures, Tables, and Topics from this paper
Paper Mentions
News Article
Interventional Clinical Trial
The purpose of the study is to observe the effect of sorafenib combined with aspirin in
preventing the recurrence in high-risk patients with hepatocellular carcinoma.
Conditions | Hepatocellular Carcinoma |
---|---|
Intervention | Drug, Other |
News Article
1,184 Citations
Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials
- Medicine
- The Lancet
- 2012
- 737
Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials
- Medicine
- The Lancet
- 2012
- 690
- PDF
Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials.
- Medicine
- The Lancet. Oncology
- 2012
- 609
- PDF
Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials
- Medicine
- The Lancet
- 2018
- 142
- PDF
Aspirin as an adjuvant treatment for cancer: feasibility results from the Add-Aspirin randomised trial.
- Medicine
- The lancet. Gastroenterology & hepatology
- 2019
- 13
- PDF
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial
- Medicine
- The Lancet
- 2011
- 731
- PDF
Individualised prediction of alternate-day aspirin treatment effects on the combined risk of cancer, cardiovascular disease and gastrointestinal bleeding in healthy women
- Medicine
- Heart
- 2014
- 38
- PDF
Daily aspirin use and cancer mortality in a large US cohort.
- Medicine
- Journal of the National Cancer Institute
- 2012
- 68
- PDF
Low-dose aspirin and cancer mortality: a meta-analysis of randomized trials.
- Medicine
- The American journal of medicine
- 2012
- 55
References
SHOWING 1-10 OF 60 REFERENCES
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials
- Medicine
- The Lancet
- 2010
- 1,017
Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies
- Medicine
- The Lancet
- 2007
- 544
Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial.
- Medicine
- JAMA
- 2005
- 235
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.
- Medicine
- Lancet
- 2009
- 1,617
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
- The Lancet
- 2009
- 1,433
- PDF
Cost-Effectiveness of Aspirin Treatment in the Primary Prevention of Cardiovascular Disease Events in Subgroups Based on Age, Gender, and Varying Cardiovascular Risk
- Medicine
- Circulation
- 2008
- 98
- PDF
Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial.
- Medicine
- JAMA
- 2008
- 507
- PDF
Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials.
- Medicine
- Journal of the National Cancer Institute
- 2009
- 393
- PDF